Literature DB >> 1389005

Blood-CSF barrier permeability and central nervous system immunoglobulin G in schizophrenia.

D G Kirch1, R C Alexander, R L Suddath, N M Papadopoulos, C A Kaufmann, D G Daniel, R J Wyatt.   

Abstract

The ratio of albumin in cerebrospinal fluid (CSF) to serum may serve as an index of the integrity of the blood-CSF barrier, with increases in this ratio indicating increased permeability. The ratio of immunoglobulin G (IgG) in CSF to serum (divided by the albumin ratio to correct for variance in blood-CSF permeability) represents an index of the endogenous production of IgG in the central nervous system (CNS), with increases reflecting a possible infectious and/or autoimmune process stimulating central IgG synthesis. We analyzed simultaneously collected CSF and serum samples from 46 schizophrenic subjects, 8 of whom were studied both on and off neuroleptic treatment, and samples from 20 normal controls. The data indicated increases in CSF/serum albumin ratios or CSF/serum IgG indices in 22% and 20%, respectively, of the schizophrenic patients. Only 3 patients showed elevations in both indices. Comparison of values on and off neuroleptics indicated no significant effect of neuroleptics on these indices.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1389005     DOI: 10.1007/bf01250674

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  35 in total

Review 1.  Is schizophrenia a viral or immunologic disorder?

Authors:  L E DeLisi; T J Crow
Journal:  Psychiatr Clin North Am       Date:  1986-03

2.  Right vs. left hemispheric blood-brain barrier permeability in schizophrenia: a dynamic computed tomographic study.

Authors:  E M Burns; H A Nasrallah; M H Kathol; T W Kruckeberg; J A Coffman
Journal:  Psychiatry Res       Date:  1987-11       Impact factor: 3.222

3.  Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis.

Authors:  H Link; G Tibbling
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

Review 4.  Schizophrenia: proteins in blood and cerebrospinal fluid. A review.

Authors:  E Bock; O J Rafaelsen
Journal:  Dan Med Bull       Date:  1974-05

Review 5.  Study of cerebrospinal fluid in schizophrenics--a review of the literature.

Authors: 
Journal:  Psychopharmacol Bull       Date:  1973-01

6.  Measurement of IgG and albumin content of cerebrospinal fluid, and its interpretation.

Authors:  K Ganrot; C B Laurell
Journal:  Clin Chem       Date:  1974-05       Impact factor: 8.327

7.  Impairment of the blood-brain barrier as an aetiological factor in paranoid psychosis.

Authors:  R Axelsson; E Martensson; C Alling
Journal:  Br J Psychiatry       Date:  1982-09       Impact factor: 9.319

8.  Altered white cell count, protein concentration and oligoclonal IgG bands in the cerebrospinal fluid of many patients with acute psychiatric disorders.

Authors:  A Ahokas; M L Koskiniemi; A Vaheri; R Rimón
Journal:  Neuropsychobiology       Date:  1985       Impact factor: 2.328

9.  Oligoclonal bands in acute schizophrenia: a negative search.

Authors:  J R Stevens; N M Papadopoulos; M Resnick
Journal:  Acta Psychiatr Scand       Date:  1990-03       Impact factor: 6.392

10.  Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction.

Authors:  J B Winfield; M Shaw; L M Silverman; R A Eisenberg; H A Wilson; D Koffler
Journal:  Am J Med       Date:  1983-05       Impact factor: 4.965

View more
  17 in total

Review 1.  Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?

Authors:  Nenad Vasic; Bernhard J Connemann; Robert C Wolf; Hayrettin Tumani; Johannes Brettschneider
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-12-16       Impact factor: 5.270

Review 2.  The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.

Authors:  Emily G Severance; Dag Tveiten; Lief H Lindström; Robert H Yolken; Karl L Reichelt
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

3.  Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases.

Authors:  J Brettschneider; A Claus; J Kassubek; H Tumani
Journal:  J Neurol       Date:  2005-04-01       Impact factor: 4.849

4.  Study factors influencing ventricular enlargement in schizophrenia: a 20 year follow-up meta-analysis.

Authors:  Angelo Sayo; Robin G Jennings; John Darrell Van Horn
Journal:  Neuroimage       Date:  2011-07-20       Impact factor: 6.556

Review 5.  Gastroenterology issues in schizophrenia: why the gut matters.

Authors:  Emily G Severance; Emese Prandovszky; James Castiglione; Robert H Yolken
Journal:  Curr Psychiatry Rep       Date:  2015-05       Impact factor: 5.285

Review 6.  Viruses, schizophrenia, and bipolar disorder.

Authors:  R H Yolken; E F Torrey
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

7.  IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia.

Authors:  Emily G Severance; Kristin L Gressitt; Armin Alaedini; Cathrin Rohleder; Frank Enning; J Malte Bumb; Juliane K Müller; Emanuel Schwarz; Robert H Yolken; F Markus Leweke
Journal:  Brain Behav Immun       Date:  2014-09-20       Impact factor: 7.217

Review 8.  Not Just a Bystander: The Emerging Role of Astrocytes and Research Tools in Studying Cognitive Dysfunctions in Schizophrenia.

Authors:  Chia-Yuan Chang; Da-Zhong Luo; Ju-Chun Pei; Ming-Che Kuo; Yi-Chen Hsieh; Wen-Sung Lai
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

9.  Microscopic particles in two fractions of fresh cerebrospinal fluid in twins with schizophrenia or bipolar disorder and in healthy controls.

Authors:  Viktoria Johansson; Rolf Nybom; Lennart Wetterberg; Christina M Hultman; Tyrone D Cannon; Anette G M Johansson; Carl Johan Ekman; Mikael Landén
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

10.  Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders.

Authors:  Maria Fiorentino; Anna Sapone; Stefania Senger; Stephanie S Camhi; Sarah M Kadzielski; Timothy M Buie; Deanna L Kelly; Nicola Cascella; Alessio Fasano
Journal:  Mol Autism       Date:  2016-11-29       Impact factor: 7.509

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.